Bedside treatment of retinopathy of premeturity by laser photocoagulation
LI Qiu-Ping, WANG Zong-Hua, CHEN Yao-Qin, CHEN Jia, HUANG Jie-Ting, WANG Zi-Zhen, FENG Zhi-Chun
Neonatal Intensive Care Unit, Bayi Children's Hospital Affiliated to the Beijing Military Region General Hospital, Beijing 100700, China. Email: zhjfengzc@126.com
Abstract：OBJECTIVE: To study the efficacy of bedside treatment by laser photocoagulation for retinopathy of prematurity (ROP) in preterm infants hospitalized in the Neonatal Intensive Care Unit (NICU). METHODS: The clinical data of 30 cases of ROP who underwent peripheral laser ablation on bedside in the NICU from March to August 2009 were studied retrospectively. RESULTS: A total of 59 eyes from 30 patients received the laser therapy, with a total cure rate of 95%. According to the International Classification of ROP, 26 eyes of 13 infants had zone 1 disease, and 33 eyes of 17 infants had zone 2 disease. The birth gestational age and birth weight as well as corrected gestational age and corrected weight at operation in the zone 1 disease group were significantly lower than those in the zone 2 disease group. The number of laser spots in the zone 1 disease group was significantly higher than that in the zone 2 disease group. The cure rate in the zone 2 disease group (100%) was significantly higher than that in the zone 1 disease group (88%). CONCLUSIONS: Laser retinal photocoagulation on bedside in the NICU is effective for both zone 1 and zone 2 ROP. As compared with the infants with zone 2 disease, the infants with zone 1 disease may have a poor outcome. ［Chin J Contemp Pediatr, 2010, 12 (9):696-699］
LI Qiu-Ping,WANG Zong-Hua,CHEN Yao-Qin et al. Bedside treatment of retinopathy of premeturity by laser photocoagulation[J]. CJCP, 2010, 12(09): 696-699.
［1］Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial［J］.Trans Am Ophthalmol Soc, 2004, 102:233-248.
［2］American Academy of Pediatrics, Section on Ophthalmology;American Academy of Ophthalmology,American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity［J］. Pediatrics, 2006, 117 (2):572-576.
［4］Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study［J］. Pediatrics, 2005, 116（1）:15-23.
［6］Park P，Eagle RC，Tasman WS. Diode laser photocoagulation for retinopathy of prematurity: a histopathology study［J］. Ophthalmic Surg Lasers, 2001, 32（1）:63-66.
［7］Al Ghamdi A, Albiani DA, Hodge WG, Clarke WN. Myopia and astigmatism in retinopathy of prematurity after treatment with cryotherapy or laser photocoagulation［J］.Can J Ophthalmo, 2004, 39（5）:521-525.
［8］Gotz-Wieckowska A, Kociecki J, Burchardt-Kroll E, Gadzinowski J. The results of diode treatment of active phase of retinopathy of prematurity［J］. Klin Oczna, 2003, 105（6）:395-397.
［9］Foroozan R, Connolly BP, Tasnan WS. Outcomes after laser therapy for threshold retinopathy of prematurity［J］. Ophthalmology, 2001, 108（9）:1644-1646.
［11］Rezai KA, Eliott D, Ferrone PJ, Kim RW. Near confluent laser photocoagulation for the treatment of threshold retinopathy of prematurity［J］. Arch Ophthalmol, 2005, 123(5):621-626.
［12］Palmer EA, Hardy RJ, Dobson V, Phelps DL, Quinn GE, Summers CG, et al. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity［J］. Arch Ophthalmol, 2005, 123（3）: 311-318.
